A
$ Value
$0
Shares
27,907
Price
$0
Filed
Apr 2
Insider
Name
CHAOUKI STEVEN M
Title
—
CIK
0001776865
Roles
Director
Transaction Details
Transaction Date
2026-03-31
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
27,907
Footnotes
The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
Filing Info
CHAOUKI STEVEN M's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-02 | TRU | ▼ | $350K |
| 2026-03-31 | MAIA | A | $0 |
| 2026-03-02 | TRU | ▼ | $383K |
| 2026-02-27 | TRU | A | $0 |
| 2026-02-27 | TRU | F | $835K |
| 2026-02-10 | TRU | A | $0 |
| 2026-01-02 | TRU | ▼ | $86K |
| 2025-12-31 | MAIA | A | $0 |
| 2025-12-22 | MAIA | ▲ | $50K |
| 2025-12-22 | MAIA | ▲ | $56K ★ |
Other Insiders at MAIA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Smith Stan | — | — | 2026-03-31 |
|
Gryaznov Sergei
Chief Scientific Officer
|
— | — | 2026-04-10 |
| Guerrero Ramiro | — | — | 2026-03-31 |
|
Vitoc Vlad
Chief Executive Officer
|
— | — | 2026-04-10 |
| Louie Ngar Yee | — | — | 2026-03-31 |
| Luput Cristian | — | — | 2026-03-31 |
| Theagene Jean-Manasse | — | — | 2026-03-31 |
|
Himmelreich Jeffrey C
Head of Finance
|
— | — | 2026-04-10 |